Cancer - Press review (January 7, 2012) – Revue de presse (7 janvier 2012)



Cancer – Press Review – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press review (January 7, 2012) – Revue de presse (7 janvier 2012)


Cancer death rates continue to drop
Small but continued drops in cancer incidence and deaths in the United
States in recent years are charted in a new report.
By Amanda Gardner. In USA Today
http://yourlife.usatoday.com/health/medical/cancer/story/2012-01-05/Cancer-death-rates-continue-to-drop/52387824/1

Photoacoustic device identifies cancer before tumors form
Early detection of skin cancer may soon be possible, thanks to
researchers who compare their approach to looking for a black 18-
wheeler in an eight-lane highway of white cars.
Par Elizabeth Armstrong Moore. In CNet.com
http://news.cnet.com/8301-27083_3-57353451-247/photoacoustic-device-identifies-cancer-before-tumors-form/

'Radioactive Paint' Could Cure Skin Cancer Tumours In Two Hours, Claim
Scientists
Italian scientists have discovered a new, non-surgical skin cancer
treatment using radioactive 'paint' which could save up to 3,000 lives
a year - and can be done in as little as two hours.
By Kyrsty Hazell. In Huffington Post
http://www.huffingtonpost.co.uk/2012/01/06/cream-could-cure-skin-cancer-in-two-hours_n_1189136.html?ref=uk

Scientists identify lung cancer stem cells and new drug targets
Singapore scientists, headed by Dr. Bing Lim, Associate Director of
Cancer Stem Cell Biology at the Genome Institute of Singapore (GIS), a
research institute under the umbrella of the Agency for Science,
Technology and Research (A*STAR), and Dr Elaine Lim, medical
oncologist affiliated with Tan Tock Seng Hospital (TTSH) and National
Cancer Centre Singapore (NCCS), have, for the first time, identified a
gene responsible for lung cancer. The finding, reported in the
advanced online issue of Cell on 5 January 2012, is a huge step
towards finding a cure for the disease.
In Medical XPress
http://medicalxpress.com/news/2012-01-scientists-lung-cancer-stem-cells.html

'Amazing' Prostate Cancer Marker: Paper Now Retracted
A cloud has descended over research into a biomarker for prostate
cancer — early prostate cancer antigen-2 (EPCA-2) — which was
described as "amazing" and appeared to overcome some of the
shortcomings of prostate-specific antigen.
By Nick Mulcahy. In Medscape
http://www.medscape.com/viewarticle/756435

Cutaneous Melanoma Risk Higher Among Cancer Survivors
A study published in the December issue of the Archives of
Dermatology, one of the JAMA/Archives journals reveals that, cancer
survivors have a higher chance of developing cutaneous melanoma (CM),
one of the most aggressive forms of skin cancer. Individuals with
previously diagnosed melanoma are at the highest risk.
By Grace Rattue. In Medical News Today
http://www.medicalnewstoday.com/articles/239922.php

Bacteria from Bay of Fundy shows potential fighting cancer
Researchers looking for ways to help protect farmed fish from
infection are now optimistically eyeing strains of bacteria from the
Bay of Fundy as potential cancer-fighters in humans.
By Shawn Berryl. In New Brunswick Telegraph-Journal
http://www.montrealgazette.com/health/Bacteria+from+Fundy+shows+potential+fighting+cancer/5953779/story.html

New drug screening identifies chemical agents with potent anti-cancer
activity
Drugs already approved for clinical use across a variety of
therapeutic categories can be screened to identify effective agents
for thyroid cancer according to a recent study accepted for
publication in the Endocrine Society's Journal of Clinical
Endocrinology & Metabolism (JCEM). These findings could rapidly be
implemented into a clinical trial to test how effective the treatment
would be..
In Medical XPress
http://medicalxpress.com/news/2012-01-drug-screening-chemical-agents-potent..html

Smoking Doubles Cancer Risk in Barrett's Esophagus
Smoking tobacco more than doubles the risk that Barrett’s esophagus
will progress to adenocarcinoma or high-grade dysplasia, Dr. Helen G.
Coleman and her colleagues wrote in the February issue of
Gastroenterology.
By Denise Napoli. In Oncology Report.
http://www.oncologyreport.com/news/clinical/single-article/smoking-doubles-cancer-risk-in-barrett-s-esophagus/1a14d1810c.html

Fibroblasts contribute to melanoma tumor growth: study
Fibroblasts, cells that play a role in the structural framework of
tissues, play an apparent role in melanoma tumor growth. Fibroblasts
also contribute to melanoma drug resistance and may also facilitate
the "flare" response when a tumor's metabolism is enhanced following a
patient being removed from a targeted therapy, said researchers at
Moffitt Cancer Center in Tampa, Fla.
In Medical XPress
http://medicalxpress.com/news/2012-01-fibroblasts-contribute-melanoma-tumor-growth.html

Top 10 cancer breakthroughs of 2011
Breast cancer prevention drug and prostate cancer 'drug holiday' make
list.
In CBC.ca
http://www.cbc.ca/news/health/story/2012/01/04/top10-cancer-breakthroughs.html

Chinese city finds cancer-causing fungi in food
Chinese food safety regulators in the southern city of Shenzhen have
found carcinogenic mildew in peanuts and cooking oil, the official
Xinhua news agency reported on Friday.
By Melanie Lee. Reuters
http://www.reuters.com/article/2011/12/30/idUSL3E7NU3JZ20111230

Ovarian cancer drug fail (and that’s the good news?)
How bad is ovarian cancer? Here’s how bad: A drug that fails to
prolong the lives of ovarian cancer patients was just declared the
biggest breakthrough in 15 years.
According to results of two international clinical trials, published
last week, the drug Avastin (aka bevacizumab) can interfere with blood
vessel growth, and thereby slow disease progression in ovarian cancer
patients.
For three months. Three and a half, actually.
But the drug has side effects. And it costs $58,000 a year.
And yet survival rates remain the same.
Oh.
By Donna Trussell. In Washington Post
http://www.washingtonpost.com/blogs/she-the-people/post/ovarian-cancer-drug-fail-and-thats-the-good-news/2011/12/31/gIQAfteaSP_blog.html

Too Much Red Meat Linked With Higher Kidney Cancer Risk: Study
Researchers found that middle-aged adults who ate the most red meat
were 19 percent more likely to be diagnosed with kidney cancer than
those who ate the least. A higher intake of chemicals found in grilled
or barbecued meat was also linked to increased risk of the disease,
they reported in the American Journal of Clinical Nutrition.
By Genevra Pittman. In Huffington Post
http://www.huffingtonpost.com/2011/12/29/red-meat-kidney-cancer_n_1173417.html

Cancer's battlefield revealed as an array of vibrant colors
Sub-microscopic images enlarged and hung as artwork in hallways of
Peoria's Cancer Research Center.
By Pam Adams. In Peoria Journal Star
http://www.pjstar.com/news/x987652831/Cancers-battlefield-revealed-as-an-array-of-vibrant-colors




Le cancer de la prostate favorisé par la consommation de viande
rouge ?
Des scientifiques américains ont établi un lien entre la consommation
de viande rouge et le développement d’un cancer agressif de la
prostate. Une corrélation plus forte quand la viande est bien cuite.
Par Janlou Chaput. Dans Futura Sciences
http://www.futura-sciences.com/fr/news/t/medecine/d/le-cancer-de-la-prostate-favorise-par-la-consommation-de-viande-rouge_35768/

Un acide pour tuer les cellules cancéreuses‎
Un acide produit naturellement par le foie pourrait détruire des
cellules cancéreuses, a découvert une équipe de chercheurs dirigée par
l'Université Concordia, a rapporté La Presse dans son édition d'hier.
Dans Cyberpresse.
http://www.cyberpresse.ca/la-tribune/actualites/201201/06/01-4483401-un-acide-pour-tuer-les-cellules-cancereuses.php

Cancer du sein : trop de femmes interrompent prématurément leur
traitement
Une étude indique que les effets secondaires de l’hormonothérapie
conduisent de nombreuses patientes touchées par un cancer du sein à
arrêter leur traitement trop tôt, s’exposant ainsi à un risque accru
de rechute de cancer du sein..
Dans E-Santé
http://www.e-sante.fr/cancer-sein-trop-femmes-interrompent-prematurement-leur-traitement/breve/616

Les centres anticancéreux utilisaient des prothèses PIP
Les centres anticancéreux regroupés au sein de la Fédération nationale
des centres de lutte contre le cancer (FNCLCC) ont utilisé jusqu'en
mars 2010 les prothèses mammaires fabriquées par PIP, a-t-on appris
jeudi auprès de leur président.
Par Claude Canellas. Dans Le Point
http://www.lepoint.fr/fil-info-reuters/les-centres-anticancereux-utilisaient-des-protheses-pip-05-01-2012-1415818_240.php

Cancer de la thyroïde : de bons pronostics de guérison
On parle souvent du cancer du sein chez les femmes. Mais l'annonce
récente du cancer de la thyroïde de la présidente de l'Argentine,
Cristina Kirchner, pousse à faire le point sur ce cancer dont on parle
moins. Le Professeur Laurence Leenhardt, endocrinologue à l'hôpital de
la Pitié-Salpêtrière, nous éclaire.
Par Laurence Leenhardt. Dans Le nouvel Observateur
http://leplus.nouvelobs.com/contribution/228124-cancer-de-la-thyroide-de-bons-pronostics-de-guerison.html

Manel Esteller honoré par le gratin de la recherche sur le cancer
Comme tous les deux ans, le symposium de l'ISREC a fait pour trois
jours de Lausanne la capitale mondiale de la recherche sur le cancer.
L'occasion notamment de récompenser les travaux d'un jeune chercheur
espagnol, dans le domaine très prometteur de l'épigénétique.
Par Marc-André Miserez. Dans Swissinfo.ch
http://www.swissinfo.ch/fre/actualite/Honore_par_le_gratin_de_la_recherche_sur_le_cancer.html?cid=6873936

Un "foie virtuel" mis au point pour aider les chirurgiens à opérer une
tumeur
Un "foie virtuel" a été mis au point par des chercheurs européens pour
aider les chirurgiens à planifier et réaliser des opérations du foie
en leur montrant avec précision la taille et la localisation de
tumeurs, a annoncé jeudi la Commission européenne.
Dans Libération
http://www.liberation.fr/depeches/01012381490-un-foie-virtuel-mis-au-point-pour-aider-les-chiurgiens-a-operer-une-tumeur

Tester des médicaments contre le cancer sur ses propres cellules
On pourrait bientôt tester des médicaments anti-cancer en laboratoire
sur ses propres cellules, grâce à une avancée scientifique réalisée
par des chercheurs américains.
Dans Canoë
http://fr.canoe.ca/sante/archives/2012/01/20120101-142137.html

Rencontre sur le cancer du col de l’utérus
Cette maladie cause la mort de plus de 1 000 femmes par an en
Algérie.
Par Souhila Hammadi. Dans Liberté-Algérie
http://www.liberte-algerie.com/actualite/rencontre-sur-le-cancer-du-col-de-l-uterus-cette-maladie-cause-la-mort-de-plus-de-1-000-femmes-par-an-en-algerie-169025

Traitement du Cancer de la Thyroïde : Un centre de Médecine nucléaire
à Abidjan en janvier
La lutte contre le cancer de la thyroïde est une préoccupation majeure
de l’actuel gouvernement. Mais la Côte d’Ivoire ne dispose pas pour le
moment de structure adéquate pour la prise en charge des patients
souffrant de cette pathologie.
Dans Le Patriote
http://news.abidjan.net/h/421478.html








Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com










Marc Lacroix – InTextoResearch – Baelen (01/2012)
.